• What we do

    What we do +

    Bringing cloud based infrastructure, scientific expertise and full service to support the optimal design and efficient management of clinical trials, where imaging provides critical evidence of the novel compound safety and efficacy.

    Expertise

    Expertise +

    Trial design, regulatory and financial strategy for biotechnology companies involved in clinical research of immuno-oncology, inflammatory and degenerative diseases.

    Theraputic Experts

    Theraputic Experts +

    Passionate, science driven, agile team, working in close partnership with leading clinicians and imaging leaders to deliver operational, strategic and partnering support to biotech and pharma clients.

    Cloud Trial Platform

    Cloud Trial Platform +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Trial Services

    Trial Services +

    We deliver accurate and comprehensive image analytics and provide full support of early phase trials and R&D studies crucial to make go / no-go decision on further development of the compound.

    Therapeutic Areas

    Therapeutic Areas +

    We deliver the most comprehensive set of imaging markers and ensure that Sponsors and Investigators are fully informed of the treatment profile when making a decision on the success of the compound.

    Clinical Trial Team

    Clinical Trial Team +

    Dedicated team of clinical and radiology experts, software engineers and algorithm developers will be engaged to deliver bespoke end-to-end support for your imaging study.

    Expertise

    Expertise +

    Trial design, regulatory and financial strategy for biotechnology companies involved in clinical research of immuno-oncology, inflammatory and degenerative diseases.

  • Why Dynamika

    Why Dynamika +

    Delivering your study on budget and on time with the cloud based infrastructure, patented scoring methodologies for advanced imaging and a network of therapeutic and imaging experts.

    Case Studies

    Case Studies +

    Case studies and clinical routine examples of using advanced imaging and quantitative image markers for highly efficient interpretation and management of imaging data

    Dynamika for Research

    Dynamika for Research +

    Dynamika is the best link between cutting academic research and clinical trial word. We ensure that you benefit from the latest science delivered within standardized regulated environment

    Cloud Trial Platform

    Cloud Trial Platform +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Connect



    DYNAMIKA QUESTIONS:
    E: dynamika@imageanalysis.org.uk
    T: + 44 7413 022053

    PROJECT SUPPORT:
    E: support@imageanalysisgroup.com

    UK: +44 7413 022053

    USA: + 1 6177 523561



    Discuss your Study (Europe)

    T: + 44 7413 022053
    E: contact@imageanalysisgroup.com

    QABC Minster House, 272-274 Vauxhall Bridge Road, London, SW1V 1BA United Kingdom

    Discuss your Study (United States)

    T: + 1 6177 523561
    E: contact@imageanalysisgroup.com

    800 Boylston St, Boston, MA 02199, USA

Company News

Image Analysis Group and Dr. Arne Fischmann present at 10th UK Neuromuscular Translational Research Conference 22-23 March 2017

Mark Hinton, CTO of Image Analysis Group, will be attending the the 10th UK Neuromuscular Translational Research Conference at the Institute of Child Health, 30 Guildford Street London, 22-23 March 2017. He and Image Analysis Group collaborator Dr. Arne Fischmann, Chief Physician Neuroradiology at Hirslanden Klinik St.Anna, Basel will be presenting a poster on advanced [...]

Dr. Sotirios Bisdas Joins IA-Group as Advisor and Member of Clinical Advisory Board

 Image Analysis Group, (IA-Group) announced today that Dr. Sotirios Bisdas, has joined their team as an advisor and member of their expert Clinical Advisory Board.  Dr. Bisdas is currently a lead Consultant Neuro-radiologist in the Department of Neuroradiology at the National Hospital for Neurology in London, Senior Lecturer in Neuroradiology at University College London, and [...]

Dr. Mikael Boesen, Head of Clinical Advisory Board of Image Analysis Group, will be attending the European Congress of Radiology in Vienna, March 1-5, 2017

Dr. Mikael Boesen, Head of Clinical Advisory Board of Image Analysis Group, will be attending the European Congress of Radiology in Vienna, March 1-5, 2017. Dr. Boesen will be presenting on the latest innovation in medical imaging and exploring partnerships and joint ventures with academic scientists and industry partners. Dr. Boesen has worked with Image Analysis group [...]

View all news

Blog

Use of Gadolinium Based Contrast Agents – What, Why and What Is Next?

On the 10th March, EMA’s Pharmacovigilance and Risk Assessment Committee (PRAC) has recommended the suspension of the marketing authorizations for four linear gadolinium contrast agents because of evidence that small amounts of the gadolinium they contain are deposited in the brain. There are no signs of harm to the patient health. This recommendation provoked a [...]

Liver Imaging and Quantitative Biomarkers in Clinical Trials

Liver biopsy is a standard procedure for diagnosing and staging non-alcoholic fatty-liver disease. However, biopsy has a number of disadvantages, including sampling error, intra- and inter-rater variability and poor patient acceptance due to potential complications. Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Quantitative imaging is a promising approach for [...]

Image Analysis collaborates with major German Hospital Charité on the application of MRI in Musculoskeletal Diseases

Image Analysis, Charité – Universitätsmedizin Berlin and Charité Research Organisation to collaborate on furthering Research & Development of contrast enhanced MRI in musculoskeletal conditions. The collaboration will be focusing on projects such as: DCE-MRI analysis in Rheumatoid arthritis DCE-MRI and contrast enhanced Computer tomography (dynCT) comparison DCE-MRI in ankylosing spondylitis The main goals of this [...]

View more posts

Latest Tweets

RT @vRad: Report says CAD will dominate #imaging market for next 5 years due to #mammography & #MRI applications http://t.co/Divka2CZWx

RT @BioMedCentral: RT @stefaniealaimo: #MRI detects early effects of #chemotherapy on children’s hearts from @BioMedCentral blog http://t.c…

RT @OlgaKubassova: #Mammography has not reduced deaths from #breast cancer. Real need for effective #imaging for early detection - #MRI htt…

RT @OlgaKubassova: Early Treatment Start Key to RA Remission http://t.co/3AhJWLvqOB

Market growth & overview of #imageanalysis #software market driven by demand for diagnostic procedures & #technology http://t.co/wHoi0He0cL

@sarahhowardview @downingstreet brilliantly :) great event for #smallbusiness and #innovation driven enterprisers http://t.co/wJWvy5bmOe

RT @jemilad: Great talk by @OlgaKubassova on how @ImageAnalysisUK delivers objectivity, efficiency and precision in medical image analysis …